EPCAM and small cell lung carcinoma: Another 99mTc-radiolabelled Fab, nofetumomab (Verluma®) – directed against pancarcinoma glycoprotein antigen epithelial cell adhesion molecule (EpCAM) – was FDA-approved for the diagnosis of small cell lung cancer.